Asset Strategy and Investment /
Branding and Positioning /
Commercial Strategy /
Insight Generation /
Lifecycle Management /
Market Access Strategy /
Market Landscapes /
Patient Journeys /
Pricing /
Value Story Development /
Workshops and Brainstorming /
Case Study: Assessing the potential impact of biosimilars and new competitive drugs launches on US payer/physician management
Problem
A top-10 pharmaceutical company wanted to understand how upcoming market events surrounding the launch of biosimilars will impact payer management and physician prescribing behavior.
Solution
- In-depth interviews were conducted with payers and physicians to assess sensitivities to different variables influencing launch of a biosimilar Product X
- Payers’ were assessed on how their management will change based on degree price erosion, launch timing, equivalence rating, manufacturer rebates, etc.
- Physicians were tested for sensitivity to different payer restrictions, equivalence ratings, launch timing, etc.
- We also assessed the impact of new product launches on the management of the category including scenarios with and without the biosimilar
Outcome
- We presented the client with a number of identified potential risks and provided the likely impact of upcoming market events to the client’s portfolio
- We provided actionable strategies where known to prepare and address these risks and dynamics going forward